Prosecution Insights
Last updated: October 01, 2026

Sun Pharmaceutical Industries, Ltd.

Technology area: Biotechnology & Pharmaceuticals

1 pending office actions • 1 art units • 1 examiners • 0 of 1 (0%) have an AI response strategy ready • 1 patents granted in the last 365 days

Analysis

Sun Pharmaceutical Industries, Ltd. is currently managing a patent portfolio in the Biotechnology & Pharmaceuticals technology area. The data indicates there is 1 pending office action across the portfolio. This activity is localized within 1 distinct art unit, showing a concentrated effort in a specific regulatory environment.

The prosecution is overseen by a distinct examiner, named SHARMA, SANTOSH. This examiner is identified as the busiest examiner with a busiest examiner pending action. Since the pending office action is the only one active, the practitioner is dealing with a point of contact at the patent office. The distinct examiner and art unit suggest that the company's current prosecution is focused on a singular technical path. This lack of complexity in the examiner pool allows for a specific strategy tailored to the examiner involved in the case.

Written from this page's own data; every figure is computed from USPTO records and verified before publication.

Portfolio Summary

1
Total Pending OAs
1
Non-Final OAs
0
Final Rejections
0
Advisory / Quayle

Case Difficulty Mix

Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.

1
Hard (100%)
0
Medium (0%)
0
Easy (0%)
0
Unknown (0%)

Rejection Statute Mix

BucketCases
§101 + other1 (100%)

Industry Mix

How the docket's pending cases split across USPTO tech-center bands.

1
Life Sciences
100% of docket
0
Information Tech
0% of docket
0
Communications
0% of docket
0
Semiconductors
0% of docket
0
Mechanical / Eng
0% of docket
0
Business / Other
0% of docket

Time-on-OA Estimate

Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.

10 h
Manual time on pending OAs
2 h
Time saved (low, 20%)
4 h
Time saved (mid, 35%)
0.1 wks
FTE-weeks freed (mid)

Top Examiners on this docket

ExaminerApps on this docketAllow rateInterview lift
SHARMA, SANTOSH 1 73.5% +28.9%

Hard Cases (1)

Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 1 ordered by deadline are shown.

App #TitleExaminerDue in
18276606 PROCESS SHARMA, SANTOSH —

Interview Candidates (1)

Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 1 ordered by deadline are shown.

App #TitleExaminerDue in
18276606 PROCESS SHARMA, SANTOSH —

Top Art Units

Art UnitApps
1663 1

Pending Office Actions

App #TitleExaminerArt UnitStatutesStatusDue inAIFiled
18276606 PROCESS SHARMA, SANTOSH 1663 §101§102§103§112 Non-Final OA — Pending Aug 09, 2023

Managing Sun Pharmaceutical Industries, Ltd.'s Patent Portfolio?

IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month